Precision Neuroscience closes $250 million round for brain-computer interface work
MedTech Dive reports that Pershing Square, the Ackman Oxman Institute and an undisclosed life sciences fund co-led the Series D, bringing Precision’s total funding to $430 million.
TLDR
Precision Neuroscience announced the $250 million Series D on September 24, 2026. MedTech Dive reports that its Layer 7 interface sits on the brain’s surface and has FDA clearance for 30-day use. Precision says it will use the money to expand clinical work, advance Layer 7 through further FDA review and build infrastructure for commercialization.
Combined views
429
1 Source, first seen 3d ago